Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
21 results for “biotech” · Indiana · press release
become increasingly dependent on China’s biotech industry. In a 2024 Biotechnology Innovation Organization survey, 79% of American … biotech companies reported at least one contract or product agreement with a China-based or Chinese-owned manufacturer
retain, and in some cases regain, global biotech leadership. The United States does not take a coordinated approach
Chinese military. We must also reinforce the American biotech ecosystem, including through investing in alternatives to Chinese biotech
because of roadblocks to the commercial production of biotech products. This legislation will help remove these roadblocks … critical gap between transformative ideas and a new biotech product coming to market, giving biotech entrepreneurs a real
WASHINGTON – Today, U.S. Senator Todd Young
leader in biotech innovation, but we lack the infrastructure to keep up with the demand despite having
States at the forefront of the AI and biotech revolution.” In April 2025,NSCEB delivered a report
innovators,” saidRepresentative Bice. “The convergence of AI and biotech is transforming what we can do with biology … million acres of national parks and enable future biotech breakthroughs in medicine, agriculture, and industrial production,”said Representative
base and workforce, and maintain American leadership in biotech. This year’s NDAA also includes my bill … includes 17 other NSCEB recommendations that would spur biotech innovation critical to our national security and defense capabilities
global influence. This is no ordinary competition. The biotech race is the defining technological contest of the 21st … decade, Beijing has poured enormous resources into biotech research and development in a deliberate bid for global dominance
warning that the U.S.-China competition on biotech will “define the coming century.”Finally, Young discussed theSHIPS
minerals supply chain, and maintain American leadership in biotech. I look forward to working with the House … includes 14 other NSCEB recommendations that would spur biotech innovation critical to our national security and defense capabilities
total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that … industry. If the United States successfully reasserts its biotech leadership, it can ensure that the new technology makes
security. We must prioritize American agricultural and emerging biotech innovation to strengthen our food supply chain … States at the forefront of safe, market-ready biotech development. Our bipartisan package will facilitate close interagency coordination
enable the U.S. to maintain its leadership in biotech innovation, defense, and economic resilience,”said Senator Young
locked in a competition with China on biotech. On Tuesday, the National Security Commission on Emerging Biotechnologyreleased … strongest fighting force on tomorrow’s battlefields. Biotech will reshore supply chains and revitalize our manufacturing sector, creating
global competition, we need to promote American biotech innovation and manufacturing. Our legislation will provide a long-term … federal agencies aligned and working on domestic biotech priorities is critical, but our Commission has found that communication
locked in a competition with China on biotech. Today, the National Security Commission on Emerging Biotechnologyreleased a reportto … need to promote American innovation and manufacturing in biotech to end China’s global supply chain grip.” Watch
emerging technologies such as artificial intelligence, cybersecurity, biotech, and quantum computing. With strong bipartisan support across both chambers
lead not only in artificial intelligence but also biotech, quantum computing, robotics and other technologies that will
rules, not China’s. Meanwhile,tech power—AI, biotech, quantum,drones, and more—is fundamentally transforming our economy … high barrier to entry for technologies—whether AI, biotech, telecommunications, or any other foundational capability—from countries